Providers

Provider Resource Center

Research

Ketamine's Potential in Rapidly Reducing Suicidal Ideation: A Comparative Study

This study explores the rapid anti-suicidal effects of a single IV dose of ketamine in patients with severe suicidal ideation (SI), comparing it to midazolam in a controlled hospital setting. Focusing on patients with prominent SI and high suicide risk, the study aims to establish ketamine's feasibility, tolerability, and efficacy in reducing SI and depressive symptoms within 24 hours. The research will be conducted over three years, integrating standard psychiatric treatment, and provides a unique insight into ketamine's role as a potential rapid intervention in critical psychiatric emergencies.

Financial Services

Manage your account or make a payment.

Disclaimers

Financing Disclaimer: $325/month for Uplift Momentum Protocol™ (medical procedure), financed over 12 months with a total cost of $3,900, 0% interest. Approval based on internal criteria, including bank account history and a soft credit pull. Payments are auto-withdrawn monthly . Subject to $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement allowed. Governed by California law and AAA arbitration rules. View Terms & Conditions

Important Medical Disclaimers

Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.

Patients

Home
Science
Experience
Program
About
FAQ's
Financial Services
Contact

Providers

Provider Home
Practice Info
Resources
Research
Patient Referrals
Schedule Tour

Get in touch

(310) 280-4440
care@ketamineuplift.com

4640 Admiralty Way
Suite 718A
Marina del Rey, CA 90292

Directions

© 2024 Ketamine Uplift | Terms of Service | Privacy Policy